Home LiteratureArticle Details
PMID: 8553698 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Precise gene disruption in Saccharomyces cerevisiae by double fusion polymerase chain reaction.

Yeast (Chichester, England) ·Vol. 11 ·No. 13 ·1995-10-00 ·Pages 1275-80

Amberg DC, Botstein D, Beasley EM

Abstract

We adapted a fusion polymerase chain reaction (PCR) strategy to synthesize gene disruption alleles of any sequenced yeast gene of interest. The first step of the construction is to amplify sequences flanking the reading frame we want to disrupt and to amplify the selectable marker sequence. Then we fuse the upstream fragment to the marker sequence by fusion PCR, isolate this product and fuse it to the downstream sequence in a second fusion PCR reaction. The final PCR product can then be transformed directly into yeast. This method is rapid, relatively inexpensive, offers the freedom to choose from among a variety of selectable markers and allows one to construct precise disruptions of any sequenced open reading frame in Saccharomyces cerevisiae.

MeSH Terms
Alleles Base Sequence Genes, Fungal Genetic Markers Molecular Sequence Data Polymerase Chain Reaction Saccharomyces cerevisiae/genetics
Chemicals
Genetic Markers
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Amberg D C
Department of Genetics, Stanford University School of Medicine, CA 94305-5120, USA.
Botstein D
Beasley E M
Article Info
Journal
Yeast (Chichester, England)
Abbr.
Yeast
ISSN
0749-503X
Published
1995-10-00
Pages
1275-80
Language
English
Region
England
NLM ID
8607637
Subset
IM
Grants
NIGMS NIH HHS · GM46406 · United States
NIGMS NIH HHS · GM46888 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com